Lung cancer incidence trends in Iran and in six geographical regions of the country (2000 - 2005) by Bab, S. et al.
Shiraz E-Med J. 2016 June; 17(6):e38237.
Published online 2016 June 25.
doi: 10.17795/semj38237.
Research Article
Lung Cancer Incidence Trends in Iran and in Six Geographical Regions
of the Country (2000 - 2005)
Sattar Bab,1 Edris Abdifard,1,2 Yousef Moradi,3 Azadeh Faraj,2 and Mohammad Heidari4,*
1Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
2Department of Nursing, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, IR Iran
3Pars Advanced and Minimally Invasive Manners Research Center, Pars Hospital, Iran University of Medical Sciences Tehran, IR Iran
4Department of Epidemiology, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
*Corresponding author: Mohammad Heidari, Department of Epidemiology, Kermanshah University of Medical Sciences, Kermanshah, IR Iran. E-mail: Heidari_m@kmu.ac.ir
Received 2016 April 05; Revised 2016 May 23; Accepted 2016 June 18.
Abstract
Background: Lung cancer, the most common type of cancer in humans, is the leading cause of cancer deaths globally, accounting
for 1.38 million deaths per year (18.2% of all cancer deaths). Lung cancer is the third most common type of cancer in Iran.
Objectives: The present study investigated the incidence of lung cancer in six geographical regions of Iran.
Materials and Methods: Data for annual cases of lung cancer were obtained from the national cancer registry during the years
2000 - 2005. The rates of incidence were standardized using world health organization (WHO) population data, and confidence
intervals were calculated at 95%. Iran was divided into six areas according to geographical differences. The Poisson regression model
was used to test the significance of changes in the incidence rates during the study period
Results: The age-standardized rates of lung cancer for men and women increased from 0.8 and 0.3 per 100,000 people in 2000 to 4
and 1.5 in 2005, respectively. The highest rate of lung cancer was observed in the mountainous region, and the lowest rate occurred
in the western provinces of the Caspian sea region. Despite the difference in the slope of changes, there is an increasing trend in the
incidence of lung cancer in all geographical areas.
Conclusions: The current incidence rates of lung cancer in all the geographical areas examined are generally increasing. Unfortu-
nately, the rates of urbanization, environmental pollution, and smoking tendency are also increasing in Iran; to control these trends
and adjust these risk factors, officials should help more with public-program planning.
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1. Background
Lung cancer is one of the world’s most common can-
cers. For every 10.9 million cancer cases, 1.35 million are
related to lung cancer, and for every 6.7 million cancer
deaths, 1.18 million result from lung cancer (1). In the
United States, 220,000 people with lung cancer are diag-
nosed each year, and more than 157,000 of them will suc-
cumb to the disease (2). In Britain, the prevalence of lung
cancer is also an increasing issue, with a total incidence
rate of 4.41 for every 100,000 individuals, and it is consid-
ered to be the main cause of death in that country (3). In
countries such as the United States and Canada, the total
number of people who die of lung cancer is greater than
the number of deaths caused by breast, colon, and prostate
cancer combined (4, 5). According to a report issued by the
world health organization (WHO) in 2002, lung cancer was
the ninth leading cause of death and was responsible for 2%
of the total number of deaths. It is predicted that in 2030,
lung cancer will be the seventh leading cause of death and
will be responsible for 3% of all deaths (6). Lung cancer is
classified into two main types: non-microscopic lung can-
cer (NSCLC) and microscopic lung cancer (SCLC). Compris-
ing 85% of all lung cancers, microscopic lung cancer is the
more common of the two (7). There are three forms of
non-microscopic lung cancers, which are labeled based on
the type of cellular involvement: carcinomas of squamous
cells, adenocarcinoma, and carcinomas of large cells. In
total, 17.3% of people who suffer from this cancer live for
five years (7). It is worth noting that non-microscopic types
of lung cancer are treated through surgery if diagnosed at
the primary stage (8). About half the known cases occur in
developing countries, with the highest rate of lung cancer
prevalence reported in North America and Europe. The av-
erage increases have been seen in Australia, New Zealand,
and East Asia (primarily in China and Japan) (9). Today, the
rate of lung cancer is relatively low in Iran (9).
Lung cancer is more prevalent among men than
women, with 71% of all cases diagnosed in the male popula-
tion. The highest rates among men are reported in Europe
(especially Eastern Europe) and North America, while the
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highest rates among women are reported in North Amer-
ica and North Western Europe (Britain, Iceland, and Den-
mark) (9). In recent decades, the incidence of lung can-
cer has decreased in conjunction with a reduced smok-
ing prevalence, the result of anti-smoking activities and
increased public awareness in these countries (10). A so-
ciety’s lung cancer prevalence increases with the number
of its individuals who smoke (11, 12). In developing coun-
tries, such as Southeast Asia and the Indian peninsula, that
have high rates of cigarette smoking, lung cancer is cur-
rently the deadliest form of cancer (13, 14). In Iran, lung
cancer cases among men and women number 10.5 and 5.1
in 100,000, respectively. For example, from 1950 to 1980,
the rate of lung cancer deaths among Taiwanese women in-
creased from 0.9 to 8.5 per 100,000; in Japan, it increased
from 3 to 11.5 per 100,000; and in Hong Kong, it increased
from 11.4 to 28.5 per 100,000 (15). From 1980 to 1980, South
Korea’s death rate due to lung cancer grew from 1.4 to 7,
and from 1980 to 2004, it grew ten-fold (16). Among Chi-
nese women, this rate increased by approximately +153% in
2005 compared to the 1991 rate (17).
Smoking is the main risk factor for lung cancer (18).
Today, smoking is an important health issue: More than
4 million people throughout the world die as the result
of smoking. It is predicted that the number of smoking
deaths will reach to ten million annually within the next
25 years (19). A 2001 study on the incidence of smoking re-
vealed that the rate was 3.6% for Iranian women over the
age of 16 and 26% for men (20). Considering the high preva-
lence of cigarette smoking among the Iranian male pop-
ulation, the incidence of lung cancer is less than the ex-
pected rate. This cancer is the fifth most prevalent cancer
in Iran, a low rate that may be the result of under-reporting
and diagnosis. However, several recent studies have shown
gradual increases in the incidence of lung cancer (21, 22).
Other risk factors include air pollution and secondary con-
tact with cigarette smoke, as well as occupational and envi-
ronmental exposure to radon and asbestos, specific metals
(especially chromium, cadmium, and arsenic), and some
organic chemical or radioactive materials; coal smoke and
the spread of other fuels in the household are additional
risk factors. Among young people who are diagnosed with
lung cancer, in particular, genetic aptness contributes to
an increased risk (23, 24).
2. Objectives
In light of the limited number of studies on changes
in the incidence rate of lung cancer in Iran, the present
study investigated the country’s lung-cancer trend during
the years 2000 - 2005. The results are important for iden-
tifying the risk of lung cancer and for predicting its inci-
dence trend, which can be of great benefit to health policy
makers.
3. Materials andMethods
In this population-based study, data were obtained
from the national cancer registry at the centre for disease
control of the Iranian ministry of health. Each year, cancer
data are collected from all pathology departments across
the country; the extracted data are then monitored for
errors in coding, demographic information, duplicates,
and missing identities. It should be noted that, in the Is-
lamic Republic of Iran, it has been mandatory since 1984
to record and to report cases of cancer; the first report
was published in 1986. The Iranian national cancer reg-
istry was improved with the development of Pars software
in 2000. Types of cancer are classified according to the In-
ternational Classification of Disease (ICD-10), second revi-
sion. For purposes of this study, we used ICD-10 categories
C33 and C34 for lung cancer. The country was divided into
six geographical areas: the central and western Caspian
sea region (Gilan and Mazandaran provinces), the east-
ern Caspian sea region (Golestan province), the flat region
(Tehran, Qom, Qazvin, Zanjan, East Azerbaijan, West Azer-
baijan, and Ardebil provinces), the mountainous region
(Kermanshah, Kurdestan, Hamedan, Ilam, Chaharmahal
va Bakhtiari, and Kohkiluye va Buyerahmad provinces), the
desert region (Fars, Kerman, Sistan va Baluchistan, Yazd,
Semnan, Khorasan, Birjand, and Isfahan provinces), and
the Persian gulf region (Khuzestan, Bushehr, and Hormoz-
gan provinces). Cases with no information on residential
provinces were considered in the calculation of the over-
all national incidence rate and not in calculations for the
different geographical regions. For incidence standard-
ization, the results of the national population consensus
of 2006 were used. Considering the annual population
growth rate of 1.01%, the population of different geograph-
ical regions was determined for 2000, 2001, 2002, 2003,
2004, and 2005. Standard population data from WHO was
used as the reference population. Using direct methods
and STATA software, version 11, age sex incidence rates and
a 95% confidence interval (CI) for the whole country and
for the six geographical regions were calculated. The sig-
nificance of incidence trends was tested via the use of a
Poisson regression model. All graphs were drawn using Mi-
crosoft Excel 2007.
4. Results
During the 5-year study, an overall number of 2,268
cases of lung cancer were recorded in Iran; the number
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of cases ranged from 397 in 2000 to 1,871 in 2005, with a
female to-male ratio of 2.99. The subjects’ mean age was
62.72 years (SD = 13.04). The women’s mean age was 59.87
years (SD = 14.29), and the men’s mean age was 63.67 years
(SD = 12.46). The standard incidence rate of breast cancer is
increasing in Iran: Overall, among both genders, it has in-
creased from 0.5 cases per 100,000 in 2000 to 2.8 cases per
100,000 in 2005.The incidence-rate standard age among
men was significantly higher than that for women. The
rate for men increased from 0.8 cases per 100,000 in 2000
to 4.00 cases per 100,000 in 2005, while the rate for women
increased from 0.3 in 2000 to 1.5 cases per 100,000 in 2005
(Table 1).
4.1. Eastern Caspian Sea Region
By ranking all regions, it is obvious that the rate of lung
cancer in this area was lower than the country’s average
during the study and had the lowest incidence rate of the
six geographical areas studied. The general rate of lung
cancer in the region on the eastern border of the Caspian
sea region decreased during the first two years of the study;
beginning in 2002, the incidence rate showed an increas-
ing trend. The incidence trend among both genders saw
many fluctuations from 2000 to 2005. Among men, the
rate increased from 0.00 cases per 100,000 in 2000 to 1.3
cases in 2005; among women, it increased from 0.000
cases per 100,000 in 2000 to 0.8 in 2005. Generally, the
rate was more severe among men. The incidence trend for
this type of cancer in the eastern border of the Caspian Sea
region increased for both genders from 2000 to 2001. In
2002, the incidence rate among males decreased, and in
2003 it increased. Following the study, the rate increased
from 0.3 cases per 100,000 in 2003 to 0.8 cases in 2004; dur-
ing the same time frame, the incidence rate among women
decreased from 0.4 to 0.3 cases per 100,000. Both genders
experienced increased rates in 2005, with 1.3 cases for men
per 100,000 and 0.8 cases for women, which were the high-
est incidence rates for both genders during the study.
4.2. Central andWestern Caspian Sea region
This region was ranked as having the fourth highest in-
cidence rate of lung cancer of the geographic areas exam-
ined. In this area, the rate of lung cancer was lower than the
country average. During the first two years of the study, the
rate increased and then decreased. Like the Eastern bor-
der of the Caspian sea region, the rate of cancer increased
from the 2002 rate. In general, the rate increased for both
genders, with 0.6 cases per 100,000 men in 2000, reach-
ing 3.2 in 2005, and with 0.2 cases per 100,000 women in
2000, reaching 1.1 in 2005. The lung cancer rate among the
men in this region decreased from 2000 to 2001; the trend
then continued to increase until the end of the study. In
2005, the rate reached 3.2 cases per 100,000. During the
period 2000 - 2001, the rate among women remained un-
changed, then increased, with a constant slope in 2002 and
2003 compared to the first two years of the study; it then
decreased in 2004 and reached its peak in 2005.
4.3. Desert Region
After the Persian gulf border area, the desert region
ranked second as the riskiest geographic area in Iran. The
rate of lung cancer in the first two years of the study was
the same; from 2003, the rate of this cancer among men
continued to increase until the end of study, reaching its
highest level in 2005 (2.7 cases per 100,000) compared to
the year 2000 (0.8 cases per 100,000). Among women, the
rate also increased, from 0.4 cases per 100,000 in 2000 to
1.4 in 2005. Generally, the rate was higher for men than
women. The lung cancer trend varied with respect to gen-
der. The rate fluctuated for men and in 2005 reached its
highest level. In women, the trend had a constant slope
during the first three years, and, suddenly, in 2003, it sig-
nificantly decreased; beginning in 2003, the trend again
increased until 2005, when it reached its highest level.
4.4. Flat Region
The flat region ranked fifth among the six geographic
areas of the study. This area had the lowest rate of lung
cancer compared to the country’s average rate. In the first
two years of the study, the rate increased and then sud-
denly decreased. Beginning in 2002, the cancer rate in-
creased and in 2005 reached its highest level. The rate
among men increased from 0.6 cases per 100,000 in 2000
to 5.3 in 2005; among women, the rate increased from 0.2
cases per 100,000 in 2000 to 1.8 in 2005. The rate gener-
ally increased among both genders. For men, the rate in-
creased from 2000 to 2001; in 2002, it suddenly decreased,
and beginning in 2002 and through the end of the study,
it continued to increase with a high slope. Among women,
the range of variation constantly increased.
4.5. Mountainous Region
In this area, the rate was lower than the country’s aver-
age rate. It ranked third after the border of the Persian gulf
and desert areas. The rate in this area generally increased
during the first two years of the study, remained constant
during the next two years, and increased to a rate higher
than that of the first two years of the study; it finally was
fixed at a rate that was higher than that during the first
four years of the study. Among the men in this area, the
rate increased from 0.7 cases per 100,000 in 2000 to 2.4 in
2005; among women, the rate increased from 0.2 cases per
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Table 1. Trend of Changes in the Age-Standardized Incidence Rate (Per 100,000 Persons) of Lung Cancer in Six Geographical Areas in Iran during 2000 - 2005
79 80 81 82 83 84 Slope/P Value
Center andwestern border of Caspian
sea region
Male 0.6 (.03 - 0.9) 0.01 (0 - 0.3) 0.9 (0.5 - 1.4) 1.8 (1.2 - 2.3) 2.3 (1.7 - 2.9) 3.2 (2.5 - 03.9) -0.13 (0.5)
Female 0.2 (0.0 - 0.4) 0.2 (0.0 - 0.4) 0.5 (0.2 - 0.8) 0.5(0.2 - 0.8) 0.4 (0.2 - 0.7) 1.1 (0.7 - 1.5) -0.38 (0.9)
Total 0.3 (0.2 - 0.5) 0.1 (0.0 - 0.2) 0.7 (0.5 - 1.0) 1.1 (0.8 - 1.4) 1.3 (0.9 - 1.6) 2.1 (1.7 - 2.6) 0.12 (0.6)
Eastern border of Caspian sea region
Male 0.0 (0.0 - 0.0) 1.4 (0.3 - 2.6) 0.0 (0.0 - 0.0) 0.3 (0.0–0.8) 0.8 (0.0 - 1.6) 1.3 (0.3 - 2.3) -0.1 (0.7)
Female 0.0 (0.0 - 0.0) 1.0 (0.0 – 2.0) 0.0(0.0 - 0.0) 0.4 (0.0 - 0.9) 0.3 (0.0 - 0.8) 0.8 (0.0 - 1.6) -0.17 (0.7)
Total 0.0 (0.0 - 0.0) 1.2 (0.5 - 2.0) 0.0 (0.0 - 0.0) 0.3 (0.0 - 0.7) 0.6 (0.1 - 1.0) 1.1 (0.4 - 1.7) -0.12 (0.7)
Desert region
Male 0.8 (05 - 1.0) 0.07 (0.5 - 01) 0.9 (0.7 - 1.1) 0.6 (0.4 - 0.8) 1.3(1.0 - 1.6) 2.7 (2.3 - 3.1) -0.01 (0.7)
Female 0.4 (0.2 - 0.5) 0.4 (.02 - 0.5) 0.4 (0.2- .06) 0.1 (0.1 - 0.2) 0.4 (0.2 - 0.6) 1.4 (1.1- 1.7) -0.24 (0.6)
Total 0.6 (0.4 - 0.07) 0.6 (0.4 - 0.7) 0.7 (0.5 - 0.8) 0.4 (0.3 - 0.5) 0.9 (0.7 - 1.0) 2.1 (1.8 - 2.3) -0.12 (0.6)
Flat region
Male 0.6 (0.5 - 0.8) 0.9 (0.6 - 1.1) 0.6 (0.4 - 0.8) 1.7 (1.3–2) 3.5 (3 - 3.9) 5.3 (4.7 - 5.9) 0.14 (0.5)
Female 0.2 (0.1 - 0.3) 0.3 (0.2–0.5) 0.3 (0.1 - 0.4) 0.3 (0.2 - 0.5) 0.9 (0.6 - 1.1) 1.8 (1.4 - 2.1) 0.68 (0.8)
Total 0.4 (0.3 - 0.5) 0.6 (0.5 - 0.7) 0.5 (0.3 - 0.6) 1.0 (0.8 - 1.2) 2.2 (1.9 - 2.5) 3.6 (3.2 - 3.9) 0.12 (0.6)
Mountainous region
Male 0.7 (0.0 –) 1.4 (1.0 - 1.8) 1.8 (1.4 - 2.2) 1.8 (1.4 - 2.2) 2.6 (2.1 - 3.1) 2.4 (2.0 - 2.9) 0.02 (0.9)
Female 0.2 (0.1 - 0.4) 0.6 (0.3 - 0.8) 0.5 (0.3 - 0.7) 0.5 (0.3 - 0.7) 0.6 (0.4 - 0.8) 0.8 (0.5 - 1.0) -0.71 (0. 8)
Total 0.5 (0.3 - 0.6) 1.0 (0.8 - 1.2) 1.2 (0.9 - 1.4) 1.2 (0.9 - 1.4) 1.6 (1.4 - 1.9) 1.6 (1.4 - 1.9) -0.21 (0.9)
The border of Fars gulf region
Male 1.1 (0.5 - 1.6) 2.4 (1.7 - 3.2) 1.5 (0.9 - 2.1) 2.1 (1.4 - 2.8) 3.5 (2.6 - 4.4) 5.2 (4.1 - 6.2) -0.25 (0.8)
Female 0.3 (0.1 - 0.6) 1.1 (0.6 - 1.6) 0.6 (0.2 - 1.0) 0.8 (0.4 - 1.2) 0.8 (0.4 - 1.2) 1.5 (0.9 - 2.1) -0.01 (0.7)
Total 0.7 (0.4 - 1.0) 1.8 (1.3 - 2.2) 1.1 (0.7 - 1.4) 1.5 (1.1 - 1.9) 2.2 (1.7 - 2.7) 3.4 (2.8 - 4.0) -0.44 (0.8)
Iran
Male 0.8 (0.7 - 0.9) 0.9 (0.8 - 1.1) 1.8 (0.17 - 2.0) 2.9 (2.7 - 3.1) 3.6 (3.4 - 3.8) 4.0 (3.8 - 4.2) 0.89 (0.6)
Female 0.3 (0.2 - 0.3) 0.4 (0.3 - 0.4) 0.6 (0.5 - 0.7) 0.9 (0.8 - 1.0) 1.0 (0.9 - 1.2) 1.5 (1.3 - 1.6) 0.32 (0.9)
Total 0.5 (0.5 - 0.6) 0.7 (0.6 - 0.7) 1.2 (1.1 - 1.3) 1.9 (1.8 - 2.0) 2.3 (2.2 - 2.5) 2.8 (2.6 -2.9) 0.07 (0.7)
100,000 in 2000 to 0.8 in 2005. The rate for men was higher
than that for women; among men, the rate continued to in-
crease until 2004 and reached its highest level in 2005.
4.6. Persian Gulf Border Region
This area had the highest rate, which was higher than
the country’s average. The lung cancer trend in this
area generally increased during the first two years and
suddenly dropped; beginning in 2002, it increased and
reached its highest level in 2005. The rate for men in-
creased from 1.1 cases per 100,000 in 2000 to 5.2 in 2005.
Among women, the rate increased from 0.3 cases per
100,000 in 2000 to 1.5 in 2005. Like the other areas, the
rate was higher for men than women. For men, the rate in-
creased with high slopes and reached its highest level in
2005. The rate for women fluctuated: During the first two
years, it increased, and in 2002, it suddenly decreased be-
fore reaching its highest level in 2005.
5. Discussion
Despite the increasing variation rates in all geographic
areas of the country, the slope of the variations were dif-
ferent: The highest increase occurred in the flat region,
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Figure 1. Average of Age-Standardized Rate of Lung Cancer in Six Geographical Areas
in Iran, 2000 - 2005
and the lowest increase occurred in the central and west-
ern border regions of the Caspian sea. In general, however,
the flat areas had the highest risk, and the western Caspian
sea region had the lowest risk. The rate of cancer was high
for men in all areas. Moreover, the incidence rate corre-
sponded with age: In individuals aged 60 - 69 years, the
rate reached the highest level and then decreased. Vari-
ations in rates among the younger age groups were low,
while they were was high among the older age groups.
Variations in cigarette smoking should be considered in
terms of the primary risk when interpreting increases in
lung cancer rates. In Iran, cigarette smoking is the main
risk factor for lung cancer (21). Based on the statistics,
the smoking prevalence in Iranian society is increasing.
For instance, during 1994 - 2000, the rate among men in-
creased from 2.6% to 2.9%, and among women, from 4.1% to
4.5%, especially among the younger groups (25, 26). There-
fore, it can be concluded that the increase of lung cancer
is consistent with the increase of smoking in Iran. Stud-
ies conducted in Iran have reported different estimations
of smoking prevalence. According to a ministry of health
and medical education report, in 1990, only 10.7% of indi-
viduals aged 15 - 24 years smoked, while in 2000, 17.1% of
that population smoked (27). According to statistical re-
ports by the deputy of health, 15% of the Iranian popula-
tion of 11 million smoke, and 75,000 die each year as the
result of smoking (28). According to surveys conducted by
the Tehran lipid and glucose institution, the rate of smok-
ing in Iran is 10.6%, with 22% for men and 1.2% for women
(29). To determine the cause of the high lung cancer rate in
the Persian gulf region, for example, the patterns of smok-
ing among the area’s men and women should be consid-
ered. For instance, in Shiraz, the rate of smoking among
men and women is 26% and 3.6%, respectively (20), and in
Bandar Abbas, the smoking rate is 11.7%, with 22.7% and 0.9%
for men and women, respectively (30). Therefore, it could
be argued that due to free commercial markets with Per-
sian gulf regional countries and ease of access, the rate of
smoking is higher than that of other areas of the country.
In 2005, Bushehr and Sistan Baluchistan had the highest
rates, with 30.6 and 25.5%, respectively; Ilam and Yazd had
the lowest rates, with 10% and 10.8%, respectively (31). These
percentages are consistent with the present research study
in explaining the high rate of lung cancer in the Persian
gulf border and desert areas.
On the other hand, nutrition patterns are involved in
the increases of all cancers, especially lung cancer. In Iran,
consistent with global trends, nutrition is shifting from
vegetables, fruits, and low-calorie foods to high-fat and
high-calorie foods. Studies have also revealed increases in
risk factors for cancer in Iran (32). Other studies conducted
in Iran also suggest that, with respect to nutrition, families
are substituting undesirable and low-value foods for more
nutritious, high-value foods (33). One of the factors in-
volved in the consumption of low-value foods in Iranian so-
ciety is the economic condition. High-income households
experiencing appropriate economic conditions have more
choices in terms of healthful foods (34).
According to previous research studies in Iran, food-
insecure individuals have lower incomes (35, 36). An-
other factor in Iran is related to inadequate knowledge
and awareness in terms of how to make appropriate food
choices for the household. For instance, during the years
2005 - 2007, a study was conducted on 2,500 citizens of
Tehran to investigate the dimensions of lifestyle in terms
of cancer prevention. The study revealed that, with respect
to nutrition habits, 61.3% of the respondents had relatively
desirable incomes, and yet none had nutritious diets. The
researchers therefore emphasized the importance of nu-
trition education in cancer prevention (37).
Air pollution from factories, machines, and dust-storm
particles is another factor in the prevalence of lung can-
cer. The development of urbanization, the expansion of
cities, accelerating population increases, the growth of in-
dustrial activities, and an inordinate consumption of fuels
have led to significant amounts of pollution, leading to res-
piratory and cardiovascular diseases among urban popula-
tions, as well as intensifying climate changes, climate fluc-
tuations, and ecological impacts (38). Pollution levels vary
among the different areas of Iran and, consequently, cause
different rates of lung cancer. For instance, in a study by
Jonaidi-Jafari and colleagues, the level of suspended parti-
cles in Tehran was calculated at about 34.11 g/m3 in 2005,
leading to 5,388 deaths in the city and encompassing 39.9%
of all cardiovascular deaths (39). Another study in Isfahan
estimated the level of pollutants from motor vehicles at
about 1586921.6 Kg per day in 2010 (40), accounting for in-
creases in the lung cancer rate in such areas and Iran. In
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addition to air pollution from industries, the air pollution
resulting from dust storms could also be considered. The
frequency of dust storms in dry and semi-dry regions is
significantly higher, which affects the lives of people who
reside in these areas (41, 42). Iran is a large country with
many provinces in desert areas. In the present study, the
highest rate of lung cancer was seen in the Persian gulf
border and desert areas, and the lowest rate was seen in
the northern areas, which could be due to climate patterns
and dust storms. In recent years, a number of studies have
been conducted on the issue, including a study on dust
storms and wind erosion in Khuzestan, which suggested
that the currents related to storms in Arabia and Iraq com-
prise the main cause of dust storms in this province and
that wind erosion constitutes the country’s main domes-
tic factor (42) in terms of lung cancer. In another study, the
patterns of dust-producing winds in Fars were analyzed
during the years 1993 - 2002. The findings revealed that at
sea level, the existence of low-pressure fronts on Arabia and
Iraq as a result of the lack of moisture and strong winds
and, at 500 hp, the position in front with an east-west ar-
rangement as a result of variation of dry air, causes the
transfer of dust particles to Iran; the position in front of the
high pressure front leads to the presence of dust particles
in the atmosphere (43). Another study on the occurrence
of dust storms in the western areas of Iran during 2005
- 2009 revealed that a low-pressure system in the Middle
East and the progression of transient conditions at desert
levels, in addition to the effects of a low-pressure dynamic
wave in the atmosphere, provide conditions conducive to
the transfer of dust particles (44).
Moreover, in 2008, a statistical analysis of dust storms
in Khorasan-e-Razavi during 1993 - 2005 revealed that dust
storms are common in this province and increase as they
move from north to south; additionally, most of them oc-
cur after 12:00 (45). In light of the above studies, the distri-
bution of lung cancer could be justified. In recent years,
the levels of dust particles in the western, southwestern,
and southern provinces have increased; at times, they have
reached the central parts of the country, which may lead
to many more cases of lung cancer if stakeholders do not
address the issue in the near future. While discussing the
increase of lung cancer in Iran, it is worth noting that the
level of public awareness about cancers, as well as their
symptoms and effects, have increased in recent years; for
example, Montazeri et al. investigated cancer patients and
found that 95% of the study respondents were eager to
know more about cancer (46). Moreover, the health sys-
tem in Iran has been developing significantly, and diag-
nostic and care services are improving (47), which, as the
result of a greater number of diagnoses, could account
for the increasing rate of lung cancer in Iran. The phe-
nomenon of an aging population could be another factor,
since, according to a study on the indicators of the health
perspective in Iran, the country’s mean lifespan is increas-
ing (47). Increasing lifespans in many developed countries
have caused a shift in focus to older adults (48).
The speed at which demographic variations occur in
developing countries is more phenomenal (49). According
to some studies, life expectancy in Iran in 1986 was 66 and
69 for men and women, respectively (50), while in 1996 this
index was 70.7 and 73.4 for men and women, respectively,
indicating a 4.5% increase (51). According to WHO, in 2005,
6.4% of the Iranian population were over age 60, and it is
predicted that 25.6% of both men and women will reach
this age group in 2050; if other variables are kept constant,
the per capita should be 2.5-fold until 2050 (52). Although
an increased life expectancy is good news, it is usually asso-
ciated with a reduction in physical and physiologic ability,
as well as an increased risk for chronic mental and physical
diseases.
The most important factor in interpreting the results
of the study and in explaining the increasing lung cancer
rate in Iran is consideration of the quality of the Iranian
cancer records system. The Iranian national cancer records
system, established in 1984 under the supervision of the
medical university of Tehran, published the recorded data
from 1999 (53). Recently, this system has shown increasing
rates (53). According to the Ministry of Health, the level
of records has increased from 18% in 1999 to 80% in 2005
(54), which may indicate the high level of cancers, and es-
pecially lung cancer, in Iran. Therefore, it is necessary to
pay attention to the evolving trend of the cancer records
system as had been mentioned in other cancer studies in
Iran (55-60). Though how much of the increase and what
geographic areas are related to this issue should be inves-
tigated in future studies which normally is common in
many countries by and large.
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